• Most Popular
  • Most Shared

Immtech says pneumonia drug trial on clinical hold

Wed Dec 26, 2007 11:30am EST

Dec 26 (Reuters) - Immtech Pharmaceuticals Inc IMM.A said a study to collect additional safety data on pafuramidine to support the indications of pneumocystis pneumonia and African sleeping sickness has been placed under clinical hold.

Stocks  |  Regulatory News

The company said the precautionary measure was taken after preliminary findings showed abnormal laboratory values in several volunteers following treatment with pafuramidine.

The compound, with orphan drug status, is being studied in South Africa, it said in a statement. (Reporting by Sharangdhar Limaye in Bangalore; Editing by Gopakumar Warrier)

Stocks
Regulatory News


More from Reuters

Joint Terminal Attack Controller SSgt Clinton J. Herbison, a U.S. Airman from the 817 Expeditionary Air Support Operations Squadron (EASOS) takes a break during a night mission near Honaker Miracle camp at the Pesh valley of Kunar Province August 12, 2009. Credit: REUTERS/Carlos Barria

Pictures of the Year

A look at the best photos of 2009.  Slideshow 

    PICTURES
    The Dalai Lama jokes with a nasal spray after being asked his opinion on the swine flu during a press conference after his first lecture in Lausanne, Switzerland, August 4, 2009. REUTERS/ Valentin Flauraud

    What a wacky year it's been...

    Um, what's up the Dalai Lama's nose? "Oddly Enough" editor Bob Basler rounds up the goofiest photos of the year.  Full Article 

    Oddly Enough
    A caution sign is seen next to a stock board at the Australian Securities Exchange (ASX) in Sydney September 5, 2008. REUTERS/Daniel Munoz
    Political Risk in 2010:

    Don't say we didn't warn you

    With the financial crisis (mostly) in the past, U.S. investors are eying a fresh start to the coming year. Here's a look at what speedbumps lie ahead.  Full Article 

    Global Markets